Correlation Between Edgewise Therapeutics and Oragenics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Oragenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Oragenics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Oragenics, you can compare the effects of market volatilities on Edgewise Therapeutics and Oragenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Oragenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Oragenics.
Diversification Opportunities for Edgewise Therapeutics and Oragenics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and Oragenics is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Oragenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oragenics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Oragenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oragenics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Oragenics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Oragenics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Oragenics. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 2.91 times less risky than Oragenics. The stock trades about -0.08 of its potential returns per unit of risk. The Oragenics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Oragenics on September 3, 2024 and sell it today you would earn a total of 1.00 from holding Oragenics or generate 3.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Oragenics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Oragenics |
Edgewise Therapeutics and Oragenics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Oragenics
The main advantage of trading using opposite Edgewise Therapeutics and Oragenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Oragenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will offset losses from the drop in Oragenics' long position.| Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |